Background illustration for clinical trials search

Paid Clinical Trials Hattiesburg

Discover 32 paid clinical trials in Hattiesburg, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
New

A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers

for
Pancreatobiliary Cancers, Pancreatic Ductal Adenocarcinoma
Location: Hattiesburg MS
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07769502

Phase 2, Recruiting

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

for
Advanced or Metastatic Colorectal Cancer
Location: Hattiesburg MS, Nashville TN, Houston TX, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05379595

Phase 1, Phase 2, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Hattiesburg MS, New Orleans LA, Jonesboro AR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

for
Relapsed/Refractory Follicular Lymphoma,
Location: Hattiesburg MS, Indianapolis IN, Plantation FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06149286

Phase 3, Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Hattiesburg MS, Baton Rouge LA, Jonesboro AR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Hattiesburg MS, Atlanta GA, Dallas TX, Denison TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

for
Alzheimer's Disease
Location: Hattiesburg MS, Atlanta GA, Cypress TX, Mesquite TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011745

Phase 3, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Hattiesburg MS, Covington LA, Pensacola FL,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase 3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Hattiesburg MS, Little Rock AR, Atlanta GA, Kingwood TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Petal MS, Alexander City AL, Panama City FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase 3, Recruiting

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

for
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Location: Hattiesburg MS, Metairie LA, Columbus GA, Nashville TN,
Sponsor: Lighthouse Pharmaceuticals, Inc.

Sex: All

Age: 55 - 70+

Code: NCT06847321

Phase 2, Recruiting
Featured

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia (CLL)
Location: Hattiesburg MS, Atlanta GA, Charlotte NC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT04895436

Phase 2, Recruiting